cached image

Gayle E. Woloschak - Related publications

Integrated Graduate Program in the Life Sciences Northwestern University, Evanston, IL 
Molecular Biology, Cell Biology, Biochemistry
NOTE: We are testing a new system for identifying relevant work based on semantic analysis that identifies similarities between recently published papers and the current author's publications. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches.
20 most relevant papers in past 60 days:
Year Citation  Score
2022 Bolatkan A, Asada K, Kaneko S, Suvarna K, Ikawa N, Machino H, Komatsu M, Shiina S, Hamamoto R. Downregulation of METTL6 mitigates cell progression, migration, invasion and adhesion in hepatocellular carcinoma by inhibiting cell adhesion molecules. International Journal of Oncology. 60. PMID 34913069 DOI: 10.3892/ijo.2021.5294   
2022 Nai J, Zhang J, Li J, Li H, Yang Y, Yang M, Wang Y, Gong W, Li Z, Li L, Gao C. Macrophage membrane- and cRGD-functionalized thermosensitive liposomes combined with CPP to realize precise siRNA delivery into tumor cells. Molecular Therapy. Nucleic Acids. 27: 349-362. PMID 35024246 DOI: 10.1016/j.omtn.2021.12.016   
2022 Xie XP, Laks DR, Sun D, Ganbold M, Wang Z, Pedraza AM, Bale T, Tabar V, Brennan C, Zhou X, Parada LF. Quiescent human glioblastoma cancer stem cells drive tumor initiation, expansion, and recurrence following chemotherapy. Developmental Cell. 57: 32-46.e8. PMID 35016005 DOI: 10.1016/j.devcel.2021.12.007   
2022 Alnajjar S, Nolte I, Schille JT, Sender S, Trakoolju N, Perez SV, Zechner D, Vollmar B, Junghanss C, Escobar HM. Establishment and Characterization of FusionRed Stable Transfected Canine Prostate Adenocarcinoma and Transitional Cell Carcinoma Cells. In Vivo (Athens, Greece). 36: 170-179. PMID 34972712 DOI: 10.21873/invivo.12688   
2022 Dey A, Sharp DJ. In Vitro Screening Assay for Activators of T-Cell Migration to Solid Tumors. Methods in Molecular Biology (Clifton, N.J.). 2423: 109-113. PMID 34978693 DOI: 10.1007/978-1-0716-1952-0_11   
2022 Wang D, Sun L, Okuda S, Yamamoto D, Nakayama M, Oshima H, Saito H, Kouyama Y, Mimori K, Ando T, Watanabe S, Oshima M. Nano-scale physical properties characteristic to metastatic intestinal cancer cells identified by high-speed scanning ion conductance microscope. Biomaterials. 280: 121256. PMID 34794825 DOI: 10.1016/j.biomaterials.2021.121256   
2022 Li XY, Corvino D, Nowlan B, Aguilera AR, Ng SS, Braun M, Cillo AR, Bald T, Smyth MJ, Engwerda CR. NKG7 Is Required for Optimal Antitumor T-cell Immunity. Cancer Immunology Research. PMID 35013002 DOI: 10.1158/2326-6066.CIR-20-0649   
2022 Lee KP, Baek S, Yoon MS, Park JS, Hong BS, Lee SJ, Oh SJ, Kwon SH, Lee R, Lee DH, Park KS, Moon BS. Potential anticancer effect of aspirin and 2'-hydroxy-2,3,5'-trimethoxychalcone-linked polymeric micelles against cervical cancer through apoptosis. Oncology Letters. 23: 31. PMID 34966447 DOI: 10.3892/ol.2021.13149   
2022 Qin D, Ni C, Tan B, Huang S, Deng B, Huang Z. LINC01207 promotes prostate cancer progression by sponging miR-1182 to upregulate AKT3. Oncology Letters. 23: 57. PMID 34992689 DOI: 10.3892/ol.2021.13175   
2022 Han Z, Gong C, Li J, Guo H, Chen X, Jin Y, Gao S, Tai Z. Immunologically modified enzyme-responsive micelles regulate the tumor microenvironment for cancer immunotherapy. Materials Today. Bio. 13: 100170. PMID 34938989 DOI: 10.1016/j.mtbio.2021.100170   
2022 Landry M, Nelson D, Choi E, DuRoss A, Sun C. Development of a G2/M arrest high-throughput screening method identifies potent radiosensitizers. Translational Oncology. 16: 101336. PMID 34986454 DOI: 10.1016/j.tranon.2021.101336   
2022 Haider S, Penfornis P, Claudio PP, McChesney JD, Chittiboyina AG. Balancing the efficacy vs. the toxicity of promiscuous natural products: Paclitaxel-based acid-labile lipophilic prodrugs as promising chemotherapeutics. European Journal of Medicinal Chemistry. 227: 113891. PMID 34656042 DOI: 10.1016/j.ejmech.2021.113891   
2022 Wang H, Fan Y, Chen W, Lv Z, Wu S, Xuan Y, Wang C, Lu Y, Guo T, Shen D, Zhang F, Huang Q, Gao Y, Li H, Ma X, et al. Loss of CMTM6 promotes DNA damage-induced cellular senescence and antitumor immunity. Oncoimmunology. 11: 2011673. PMID 35024247 DOI: 10.1080/2162402X.2021.2011673   
2022 Li L, Hu Y, Chen D, Zhu J, Bao W, Xu X, Chen H, Chen W, Feng R. CMTM5 inhibits the development of prostate cancer via the EGFR/PI3K/AKT signaling pathway. Molecular Medicine Reports. 25. PMID 34791506 DOI: 10.3892/mmr.2021.12533   
2022 Liu K, Hoover AR, Krawic JR, DeVette CI, Sun XH, Hildebrand WH, Lang ML, Axtell RC, Chen WR. Antigen presentation and interferon signatures in B cells driven by localized ablative cancer immunotherapy correlate with extended survival. Theranostics. 12: 639-656. PMID 34976205 DOI: 10.7150/thno.65773   
2022 Yan Z, Xia X, Cho WC, Au DW, Shao X, Fang C, Tian Y, Lin Y. Rapid Plastic Deformation of Cancer Cells Correlates with High Metastatic Potential. Advanced Healthcare Materials. e2101657. PMID 35014196 DOI: 10.1002/adhm.202101657   
2022 Guo F, Das JK, Kobayashi KS, Qin QM, A Ficht T, Alaniz RC, Song J, Figueiredo P. Live attenuated bacterium limits cancer resistance to CAR-T therapy by remodeling the tumor microenvironment. Journal For Immunotherapy of Cancer. 10. PMID 34987022 DOI: 10.1136/jitc-2021-003760   
2022 Li B, Xiao Q, Shan L, Song Y. NCAPH promotes cell proliferation and inhibits cell apoptosis of bladder cancer cells through MEK/ERK signaling pathway. Cell Cycle (Georgetown, Tex.). 1-12. PMID 34974790 DOI: 10.1080/15384101.2021.2021050   
2022 Fang F, Yuan Q. Anlotinib inhibits the proliferation, migration and invasion, and induces apoptosis of breast cancer cells by downregulating TFAP2C. Oncology Letters. 23: 46. PMID 34976158 DOI: 10.3892/ol.2021.13164   
2022 Yin L, Zhang Y, Zheng L. Analysis of differentially expressed long non‑coding RNAs revealed a pro‑tumor role of MIR205HG in cervical cancer. Molecular Medicine Reports. 25. PMID 34878159 DOI: 10.3892/mmr.2021.12558